Eddie Pan

Eddie Pan

Expertise: Institutional Investments, Insider Activity, Disruptive Innovations

Education: BBA, Finance, James Madison University

About Eddie:
Eddie Pan specializes in institutional investments and insider activity. He has been enamored with hedge funds since he began investing and regularly collaborates with industry executives to craft editorial pieces. Tracking the investments of institutional investors and insiders can provide a vast array of knowledge that is scarcely covered.

After receiving his BBA in Finance from James Madison University, Eddie began his career at Accenture as an analyst. Today, he writes for InvestorPlace’s Today’s Market team, which centers on the latest news involving popular stocks.

Eddie got his start in the financial media world by publishing articles on top-performing hedge funds and their investment strategies on Substack. He still publishes pieces on his Substack today.

Common Stocks and Uncommon Profits by Philip A. Fisher is Eddie’s favorite investment book. Fisher’s 15 Points have heavily influenced his investment strategy.

Recent Articles

Rivian Stock Alert: RIVN Shares Just Lost Out on Market Cap to LCID Stock

Lucid recently passed Rivian stock in market cap, even though Lucid has fewer reservations than Rivian. What's next for the two EV makers?

Rivian Stock Price Predictions: Where Will RIVN Go After Hitting New Lows?

Investors are getting increasingly nervous after RIVN stock hit an all-time low. Let's dive into Rivian price predictions for 2022.

EH Stock Alert: Why Is Hard-Hit EHang Climbing Higher Today?

Shares of EH stock are trading higher after the air mobility company received a large preorder. What's next for EHang?

CSPR Stock Soars on Buyout Approval. 8 Things to Know.

Casper Sleep announced that its shareholders approved its buyout from Durational Capital. What does this mean for CSPR stock?

VALN Stock Alert: 4 Things to Know About the Vaccine News Sending Valneva Soaring

Valneva is picking up attention as the biotech firm is up more than 30% today. Will its vaccine candidate power VALN stock to new highs?